Lets summarize key outcomes from the retatrutide Phase 2 study: Dramatic Average Weight Reduction: At the highest dose (12 mg weekly), participants lost ~24% of body weight by week 48, compared to just ~2% for those on placebo
Early trials have provided implication of the neuroprotective benefits of pioglitazone, which are potentially mediated by its anti-inflammatory and insulin-sensitizing effects
Recent studies have increasingly focused on the potential therapeutic role of metformin in liver fibrosis 59,60,61
Can semaglutide be used long-term
In fact, the drug's prescribing information even warns about this potential side effect, Nassar noted
In my practice, I have seen countless women who, despite their best efforts, cannot achieve their weight loss goals